| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ovid Therapeutics Inc (NASDAQ: OVID)
OVID Technical Analysis
5
| As on 9th Jun 2023 OVID STOCK Price closed @ 3.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.44 & Strong Buy for SHORT-TERM with Stoploss of 3.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OVIDSTOCK Price
| Open | 3.47 | Change | Price | % |
| High | 3.59 | 1 Day | -0.03 | -0.85 |
| Low | 3.46 | 1 Week | -0.08 | -2.25 |
| Close | 3.48 | 1 Month | 0.41 | 13.36 |
| Volume | 1038250 | 1 Year | 0.23 | 7.08 |
| 52 Week High 3.84 | 52 Week Low 1.44 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OVID Daily Charts |
OVID Intraday Charts |
Whats New @ Bazaartrend |
OVID Free Analysis |
|
|
OVID Important Levels Intraday
| RESISTANCE | 3.73 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.60 |
| RESISTANCE | 3.55 |
| SUPPORT | 3.41 |
| SUPPORT | 3.36 |
| SUPPORT | 3.31 |
| SUPPORT | 3.23 |
OVID Forecast May 2024
| 4th UP Forecast | 5.25 |
| 3rd UP Forecast | 4.68 |
| 2nd UP Forecast | 4.33 |
| 1st UP Forecast | 3.98 |
| 1st DOWN Forecast | 2.98 |
| 2nd DOWN Forecast | 2.63 |
| 3rd DOWN Forecast | 2.28 |
| 4th DOWN Forecast | 1.71 |
OVID Weekly Forecast
| 4th UP Forecast | 4.08 |
| 3rd UP Forecast | 3.89 |
| 2nd UP Forecast | 3.77 |
| 1st UP Forecast | 3.65 |
| 1st DOWN Forecast | 3.31 |
| 2nd DOWN Forecast | 3.19 |
| 3rd DOWN Forecast | 3.07 |
| 4th DOWN Forecast | 2.88 |
OVID Forecast2024
| 4th UP Forecast | 8.28 |
| 3rd UP Forecast | 6.74 |
| 2nd UP Forecast | 5.79 |
| 1st UP Forecast | 4.84 |
| 1st DOWN Forecast | 2.12 |
| 2nd DOWN Forecast | 1.17 |
| 3rd DOWN Forecast | 0.22 |
| 4th DOWN Forecast | -1.32 |
Ovid Therapeutics Inc ( NASDAQ USA Symbol : OVID )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OVID Business Profile
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed Phase II clinical trial for the treatment of fragile X syndrome in adolescent and young male adults. It is also developing OV935, a drug candidate, which has completed Phase II clinical trial for the treatment of cyclin-dependent kinase-like 5 deficiency disorder and dravet syndrome. In addition, the company undertakes research programs exploring OV329 in infantile spasm/rare epilepsies; OV882 as a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815, a gene modulation therapy for the treatment of kinesin-family of proteins associated neurological disorder. Ovid Therapeutics Inc. has a collaboration agreement with Takeda Pharmaceutical Company Limited; a license agreement with H. Lundbeck A/S; strategic research collaboration with Columbia University Irving Medical Center; and license agreement with Angelini Pharma to develop and commercialize OV101 for the treatment of angelman syndrome in Europe. The company was incorporated in 2014 and is headquartered in New York, New York. Address: 1460 Broadway, New York, NY, United States, 10036
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service